Stock GELESIS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Gelesis Inc Stock

Equities

US36850R1059

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Gelesis Inc
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Press releases Gelesis Inc

Gelesis Expands Ongoing Weight Loss Study to Serve as U.S. Pivotal Trial, Significantly Accelerating Development Timeline GL
Gelesis Presents Additional Data at European Congress on Obesity GL
More press releases

Managers and Directors - Gelesis Inc

Managers TitleAgeSince
David Pass COO
 Chief Operating Officer 56 16-08-31
Angelo Tremblay PRN
 Corporate Officer/Principal - -
Cosimo Saponaro PRN
 Corporate Officer/Principal - -
Members of the board TitleAgeSince
Clayton Christopher BRD
 Director/Board Member 51 -
Kathryn Cavanaugh BRD
 Director/Board Member 50 21-12-31
Alison Bauerlein BRD
 Director/Board Member 42 22-01-04
More insiders

Company Profile

More about the company

Sector Biopharmaceuticals

1st Jan change Capi.
CSL LIMITED Stock CSL Limited
-0.07% 91.42B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 41.08B
BIOGEN INC. Stock Biogen Inc.
-9.06% 34.26B
UCB Stock UCB
+55.32% 25.27B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.61% 15.27B
INCYTE CORPORATION Stock Incyte Corporation
-9.14% 12.81B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.11% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.61% 11.42B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+7.79% 9.16B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW